Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | +12.9K | +123.04% | 23.4K | Aug 5, 2022 | Direct | F1 | ||
transaction | OGN | Common Stock | Tax liability | -$143K | -4.42K | -18.9% | $32.41 | 19K | Aug 5, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -12.9K | -50% | $0.00 | 12.9K | Aug 5, 2022 | Common Stock | 12.9K | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
F2 | The total amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. |
F3 | On each of August 5, 2021 and August 5, 2022, one-third of the RSUs vested with the remaining RSUs to vest in one final installment on August 5, 2023. |